Photoscreening for Retinoblastoma

Phoenix Children's Hospital

Status: Withdrawn

Conditions: Retinoblastoma

Treatments: Device: Photoscreening -

Study type: Interventional

Funder types: Other

Identifiers

NCT04344652

AR01

Details and patient eligibility

About

Retinoblastoma is the most common pediatric eye malignancy and manifests between 1 and 5 years of age. The tumor is most often diagnosed by leukocoria ( white reflex in the pupil). There is often a significant delay in diagnosis and early diagnosis enables good life prognosis and better vision outcome.There is currently not a standardized screening protocol for detection of retinoblastoma. Vision screening methods are recommended for children 3-5 years of age. The investigators are attempting to use instrument based screening started from birth to detect leukocoria.

Sex: All

Ages: Under 10 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age birth to 10 years
• Informed consent given by parent or legal guardian

Exclusion criteria

• None

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Photoscreening

Experimental group

Description:

Photoscreening of patients 0 to 10 years of age

Treatment:

Device: Photoscreening -